Results 271 to 280 of about 655,517 (311)

Murine Models of Bone-Marrow Transplant Conditioning

2002
Hematopoietic stem-cell transplantation (SCT) is a rapidly evolving clinical strategy for treating a variety of malignancies or disorders of the lymphohematopoietic system. Bone-marrow cells or, more recently, mobilized peripheral blood (MPB) stem cells, are used as a vital source of hematopoietic cells that can reconstitute the host and rescue the ...
van Os, Ronald, Down, Julian
openaire   +2 more sources

Novel approaches to transplant conditioning

Hematological Oncology, 2001
Hennessy, B.J., Orchard, K.H., Potter, M.N.   +2 more
openaire   +3 more sources

Changing Approaches to Transplant Conditioning for Hematologic Malignancy

Journal of Hematotherapy, 1999
H E C L A SS IC C O N C E P T R E G A R D IN G BMT in hematologic malignancy holds that myeloablative conditioning is a prerequisite for cure. However, as many as one third of patients may die from complications after this procedure. A preliminary publication in 1985, dealing with 5 cases of accelerated CML using dibromomannitol/ cytarabine ...
openaire   +2 more sources

Conditioning regimens for allogeneic stem cell transplants

Current Opinion in Hematology, 2000
In addition to providing cytoreduction at myeloablative dose intensity, conditioning regimens for allogeneic transplantation are designed to immunosuppress the recipient to permit donor lymphohematopoietic engraftment and thereby establish a graft-versus-malignancy effect.
openaire   +2 more sources

Optimal Conditions of Transplantable Binary Polyelectrolyte Microcapsules

Annals of the New York Academy of Sciences, 2001
Abstract: Binary polyanion/oligocation microcapsules, prepared in a one‐step process, are proposed as an alternative to the common alginate/poly‐l‐lysine system used in bioencapsulation technology. The model system is based on natural polysaccharides and involves the anionic sodium alginate, or iota‐carrageenan, complexed with cationic oligochitosan ...
openaire   +2 more sources

Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial

Transplantation and Cellular Therapy, 2021
Mehdi Hamadani, Raphaël Fraser, H Joachim Deeg   +2 more
exaly  

Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis

Transplantation and Cellular Therapy, 2022
Nina Wagner-Johnston, Tania Jain, Hany Elmariah   +2 more
exaly  

Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review

Journal of Clinical Medicine, 2022
Giovanni Caocci, Mulas Olga
exaly  

Graft Condition and Mortality in Heart Transplantation

2015
G. Dureau, M. Chuzel, H. Termet, J.P. Frieh, J. Ninet, J. Villard, G. Alnashawati, B. Dugres, C. Saroul, M.C. Germain, O. Bastien, C. Hercule, C. Girard, S. Estanove, M. Perinetti, H. Betuel, A. Tabib, R. Loire, J. Etienne, M. Cellard, Y. Brun, A. Calvet   +21 more
openaire   +2 more sources

CONDITIONING REGIMEN FOR CELL TRANSPLANT

2023
HANDGRETINGER RUPERT, BOCKERMANN ROBERT, LANG PETER, MAIER CLAUS-PHILIPP   +3 more
openaire   +3 more sources